vs

Side-by-side financial comparison of NICOLET BANKSHARES INC (NIC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $104.0M, roughly 1.9× NICOLET BANKSHARES INC). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs 6.7%, a 32.1% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 12.5%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 12.5%).

Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

NIC vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.9× larger
RGEN
$197.9M
$104.0M
NIC
Growing faster (revenue YoY)
RGEN
RGEN
+1.1% gap
RGEN
13.6%
12.5%
NIC
Higher net margin
NIC
NIC
32.1% more per $
NIC
38.8%
6.7%
RGEN
More free cash flow
NIC
NIC
$131.9M more FCF
NIC
$149.4M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
12.5%
NIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NIC
NIC
RGEN
RGEN
Revenue
$104.0M
$197.9M
Net Profit
$40.3M
$13.3M
Gross Margin
52.5%
Operating Margin
48.3%
9.0%
Net Margin
38.8%
6.7%
Revenue YoY
12.5%
13.6%
Net Profit YoY
16.9%
143.9%
EPS (diluted)
$2.63
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NIC
NIC
RGEN
RGEN
Q4 25
$104.0M
$197.9M
Q3 25
$102.9M
$188.8M
Q2 25
$95.7M
$182.4M
Q1 25
$89.4M
$169.2M
Q4 24
$92.4M
$174.1M
Q3 24
$90.7M
$154.9M
Q2 24
$85.0M
$154.1M
Q1 24
$82.2M
$151.3M
Net Profit
NIC
NIC
RGEN
RGEN
Q4 25
$40.3M
$13.3M
Q3 25
$41.7M
$14.9M
Q2 25
$36.0M
$14.9M
Q1 25
$32.6M
$5.8M
Q4 24
$34.5M
$-30.3M
Q3 24
$32.5M
$-654.0K
Q2 24
$29.3M
$3.3M
Q1 24
$27.8M
$2.1M
Gross Margin
NIC
NIC
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
NIC
NIC
RGEN
RGEN
Q4 25
48.3%
9.0%
Q3 25
50.4%
8.9%
Q2 25
46.8%
7.6%
Q1 25
44.9%
3.9%
Q4 24
46.8%
-17.7%
Q3 24
45.0%
-5.1%
Q2 24
43.3%
1.0%
Q1 24
41.8%
1.3%
Net Margin
NIC
NIC
RGEN
RGEN
Q4 25
38.8%
6.7%
Q3 25
40.6%
7.9%
Q2 25
37.6%
8.2%
Q1 25
36.4%
3.4%
Q4 24
37.3%
-17.4%
Q3 24
35.8%
-0.4%
Q2 24
34.5%
2.2%
Q1 24
33.8%
1.4%
EPS (diluted)
NIC
NIC
RGEN
RGEN
Q4 25
$2.63
$0.24
Q3 25
$2.73
$0.26
Q2 25
$2.34
$0.26
Q1 25
$2.08
$0.10
Q4 24
$2.21
$-0.55
Q3 24
$2.10
$-0.01
Q2 24
$1.92
$0.06
Q1 24
$1.82
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NIC
NIC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$134.9M
$542.2M
Stockholders' EquityBook value
$1.3B
$2.1B
Total Assets
$9.2B
$2.9B
Debt / EquityLower = less leverage
0.11×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NIC
NIC
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
NIC
NIC
RGEN
RGEN
Q4 25
$134.9M
$542.2M
Q3 25
$134.6M
$537.9M
Q2 25
$134.3M
Q1 25
$156.6M
Q4 24
$161.4M
$525.6M
Q3 24
$161.2M
Q2 24
$162.4M
Q1 24
$162.3M
Stockholders' Equity
NIC
NIC
RGEN
RGEN
Q4 25
$1.3B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$2.0B
Q4 24
$1.2B
$2.0B
Q3 24
$1.1B
$2.0B
Q2 24
$1.1B
$2.0B
Q1 24
$1.1B
$2.0B
Total Assets
NIC
NIC
RGEN
RGEN
Q4 25
$9.2B
$2.9B
Q3 25
$9.0B
$2.9B
Q2 25
$8.9B
$2.9B
Q1 25
$9.0B
$2.9B
Q4 24
$8.8B
$2.8B
Q3 24
$8.6B
$2.8B
Q2 24
$8.6B
$2.9B
Q1 24
$8.4B
$2.8B
Debt / Equity
NIC
NIC
RGEN
RGEN
Q4 25
0.11×
0.26×
Q3 25
0.11×
0.26×
Q2 25
0.11×
Q1 25
0.13×
Q4 24
0.14×
0.27×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NIC
NIC
RGEN
RGEN
Operating Cash FlowLast quarter
$153.5M
$25.7M
Free Cash FlowOCF − Capex
$149.4M
$17.6M
FCF MarginFCF / Revenue
143.7%
8.9%
Capex IntensityCapex / Revenue
3.9%
4.1%
Cash ConversionOCF / Net Profit
3.81×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$275.0M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NIC
NIC
RGEN
RGEN
Q4 25
$153.5M
$25.7M
Q3 25
$45.9M
$48.1M
Q2 25
$38.9M
$28.6M
Q1 25
$41.8M
$15.0M
Q4 24
$133.7M
$39.2M
Q3 24
$39.6M
$49.3M
Q2 24
$37.3M
$42.2M
Q1 24
$23.4M
$44.7M
Free Cash Flow
NIC
NIC
RGEN
RGEN
Q4 25
$149.4M
$17.6M
Q3 25
$45.9M
$43.4M
Q2 25
$38.4M
$21.5M
Q1 25
$41.3M
$11.4M
Q4 24
$116.8M
$33.6M
Q3 24
$34.7M
$42.3M
Q2 24
$34.4M
$37.4M
Q1 24
$20.1M
$36.4M
FCF Margin
NIC
NIC
RGEN
RGEN
Q4 25
143.7%
8.9%
Q3 25
44.6%
23.0%
Q2 25
40.1%
11.8%
Q1 25
46.2%
6.8%
Q4 24
126.4%
19.3%
Q3 24
38.3%
27.3%
Q2 24
40.5%
24.3%
Q1 24
24.4%
24.0%
Capex Intensity
NIC
NIC
RGEN
RGEN
Q4 25
3.9%
4.1%
Q3 25
0.0%
2.5%
Q2 25
0.6%
3.9%
Q1 25
0.5%
2.1%
Q4 24
18.3%
3.2%
Q3 24
5.4%
4.5%
Q2 24
3.5%
3.1%
Q1 24
4.0%
5.5%
Cash Conversion
NIC
NIC
RGEN
RGEN
Q4 25
3.81×
1.93×
Q3 25
1.10×
3.23×
Q2 25
1.08×
1.92×
Q1 25
1.28×
2.57×
Q4 24
3.88×
Q3 24
1.22×
Q2 24
1.28×
12.70×
Q1 24
0.84×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons